WADA 2026: More Tests, Detection Rate Standing Still

Three years, three almost identical numbers: 0.77% — 0.80% — 0.78%. That is the Adverse Analytical Finding (AAF) rate in the latest annual report from the World Anti-Doping Agency (WADA). At the same time, global sample testing rose from 288,865 tests in 2026 to 297,965 in 2026, roughly 9,100 more samples, a 3.2% increase. That sounds positive — until you place it beside the previous year's growth rate of 12.5%. The curve is crawling. Numbers do not lie, but the people who read them do. I have tracked WADA annual reports since the years I sat in the Thanh Nien newsroom as a junior swimming reporter. I learned one rule early: a governance report should never be read like a results bulletin. It is a chain of operational data — sample volumes, detection rates, audit counts, cash flows — and its value lies in continuity, not headlines. This year's report covers several fronts. On collection, WADA publishes a 2026–2026 testing series, with a hot spike in 2026–2026 followed by clear cooling. On governance, the agency completed the 2027 World Anti-Doping Code in Busan, South Korea, effective January 1, 2027. On consultation, WADA joined the Athlete Council on an Athlete-Centered Consultation involving more than 600 athletes and commissions from over 60 countries and 70 sports. On finances, the picture is dimmer: an $8.3 million budget shortfall. For those of us in swimming, this is not a story about stroke technique. It is a story about the legal and financial frame surrounding every lane. Follow the evidence chain. Testing volume: 288,865 samples in 2026 to 297,965 in 2026. Growth rate: 12.5% for 2026–2026, then 3.2% for 2026–2026. AAF rate: 0.77% — 0.80% — 0.78%. The last three sit inside a plus-or-minus 0.03 percentage-point band, narrow enough to treat as a real baseline rather than statistical noise. This is where I want to pause longest. A system that raises sample counts without lifting its detection rate implies one of two things: either underlying doping prevalence is genuinely stable, or the system is targeting more precisely and reaching a population with comparable positivity. Public data cannot separate the two. Anyone who claims certainty is selling belief, not conclusion. The audit section is where the smell is. Average non-conformities across compliance audits fell from 25.5 to 20 — that sounds like progress. But it covers only nine audits, too small a sample to call a trend. Meanwhile, testing-related non-conformities rose 11% year-on-year, made up 45% of all findings, and 23% were rated critical. Overall improvement masks local deterioration at the single most important link: sample collection. Money tells the rest. The budget fell $8.3 million short, with the United States $3.8 million in arrears and Russia owing $3.9 million. Against that, WADA recorded a $1.2 million net surplus. What does a large shortfall alongside a small surplus mean? It means the agency is tightening spending or deferring disbursement — and in a system where money scales with samples, that is a signal worth tracking. Finally, WADA announced a shift from traditional testing toward investigations and prevention. It cited more than 250 investigative operations, 88 laboratories dismantled, and over 90 tonnes of materials seized. That is strategic reorientation, not scattered statistics. Here I have to say plainly what the headline does not. The phrase WADA increases testing creates an illusion of momentum. The data show momentum falling, not rising. A system that grows samples at 12.5% and then drops to 3.2% is not booming. It is hitting a resource ceiling. And here is the familiar trap: people assume more tests means more catches, means cleaner sport. Correlation is not causation. A flat 0.78% AAF rate may be good news, bad news, or simply neutral — depending on what you are measuring. If the system expands into low-resource nations where collection capacity is weak, detection rates can be diluted by that very expansion. Miracles are just unregressed data points — and here there is no miracle, only a flat baseline. For swimming, the consequences are indirect but real. Swimming is testing-intensive: many events, many athletes, a dense calendar. If the system's funding weakens, small swimming federations — dependent on national anti-doping budgets — are the first to feel reduced out-of-competition coverage. When the world stops turning, I build my own data cycle; but not every federation keeps its own dataset to cross-check against. January 1, 2027 is not far off. The new Code is adopted but not yet in force, which makes 2026 and 2026 a compliance-gap window where old-rule behaviour can persist. The question worth tracking is not whether WADA tests more, but whether national organisations will be ready before the new rules take effect. Data only dies when we stop asking questions.